Baird Financial Group
ARKG icon

Baird Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Baird Financial Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
73,722
+255
+0.3% +$8.12K ﹤0.01% 941
2026
Q1 		$1.94M Sell
73,467
-42,823
-37% -$1.25M ﹤0.01% 1049
2025
Q4 		$3.37M Buy
116,290
+45,425
+64% +$1.36M 0.01% 873
2025
Q3 		$1.97M Sell
70,865
-1,112
-2% -$28.1K ﹤0.01% 1051
2025
Q2 		$1.75M Buy
71,977
+32,221
+81% +$706K ﹤0.01% 1049
2025
Q1 		$825K Buy
39,756
+29,629
+293% +$744K ﹤0.01% 1245
2024
Q4 		$238K Buy
10,127
+1,765
+21% +$43.4K ﹤0.01% 1630
2024
Q3 		$214K Sell
8,362
-1,104
-12% -$28.1K ﹤0.01% 1648
2024
Q2 		$222K Sell
9,466
-1,460
-13% -$36.8K ﹤0.01% 1646
2024
Q1 		$314K Buy
10,926
+935
+9% +$28.1K ﹤0.01% 1539
2023
Q4 		$328K Sell
9,991
-1,477
-13% -$40.2K ﹤0.01% 1482
2023
Q3 		$319K Buy
11,468
+272
+2% +$8.89K ﹤0.01% 1482
2023
Q2 		$382K Sell
11,196
-123
-1% -$3.87K ﹤0.01% 1435
2023
Q1 		$340K Sell
11,319
-24
-0.2% -$744 ﹤0.01% 1453
2022
Q4 		$320K Sell
11,343
-631
-5% -$20K ﹤0.01% 1431
2022
Q3 		$394K Sell
11,974
-5,216
-30% -$191K ﹤0.01% 1361
2022
Q2 		$541K Sell
17,190
-24,812
-59% -$868K ﹤0.01% 1316
2022
Q1 		$1.93M Buy
42,002
+6,677
+19% +$318K ﹤0.01% 924
2021
Q4 		$2.16M Sell
35,325
-5,013
-12% -$347K 0.01% 906
2021
Q3 		$3.01M Buy
40,338
+11,907
+42% +$999K 0.01% 778
2021
Q2 		$2.63M Sell
28,431
-3,071
-10% -$261K 0.01% 802
2021
Q1 		$2.79M Buy
31,502
+21,853
+226% +$2.17M 0.01% 763
2020
Q4 		$900K Buy
+9,649
New +$769K ﹤0.01% 1045

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Baird Financial Group's ARKG Position: Q2 2026 in Review

Baird Financial Group increased its ARK Genomic Revolution ETF (ARKG) stake by 0.35% in Q2 2026, buying an estimated $8.12K and bringing the position to 73,722 shares worth $3.1M. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Baird Financial Group first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.37M in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Baird Financial Group held 73,722 shares of ARK Genomic Revolution ETF worth $3.1M as of Q2 2026.
  • Baird Financial Group bought 255 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $8.12K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #941 holding.
  • Baird Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Baird Financial Group's ARK Genomic Revolution ETF position peaked at $3.37M in Q4 2025.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.